Search Results - "Loughran, Kerry A"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease by Huh, Terry, Larouche‐Lebel, Éva, Loughran, Kerry A., Oyama, Mark A.

    Published in Journal of veterinary internal medicine (01-01-2021)
    “…Background Little is known about the effect of renin angiotensin aldosterone system‐inhibiting (RAASi) drugs on alternative angiotensin peptides (APs) such as…”
    Get full text
    Journal Article
  2. 2

    The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats by Loughran, Kerry A., Rush, John E., Rozanski, Elizabeth A., Oyama, Mark A., Larouche‐Lebel, Éva, Kraus, Marc S.

    Published in Journal of veterinary internal medicine (01-09-2019)
    “…Background Focused cardiac ultrasound (FCU) helps detect occult heart disease in human patients. Hypothesis Focused cardiac ultrasound by a nonspecialist…”
    Get full text
    Journal Article
  3. 3

    Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease by Larouche‐Lebel, Éva, Loughran, Kerry A., Huh, Terry, Oyama, Mark A.

    Published in Journal of veterinary internal medicine (01-01-2021)
    “…Background The pathophysiology of heart failure involves maladaptive angiotensin peptides (APs) and enzymes, including angiotensin 2 (AT2) and angiotensin…”
    Get full text
    Journal Article
  4. 4

    Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease by Li, Qinghong, Larouche-Lebel, Éva, Loughran, Kerry A, Huh, Terry P, Suchodolski, Jan S, Oyama, Mark A

    Published in Journal of the American Heart Association (04-05-2021)
    “…Background Myxomatous mitral valve disease (MMVD), a naturally occurring heart disease, affects 10% to 15% of the canine population. Canine MMVD shares many…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease by Li, Qinghong, Larouche-Lebel, Éva, Loughran, Kerry A, Huh, Terry P, Suchodolski, Jan S, Oyama, Mark A

    Published in mSystems (20-04-2021)
    “…Gut dysbiosis and gut microbiota-derived metabolites, including bile acid (BA), short-chain fatty acid, and trimethylamine -oxide (TMAO), are associated with…”
    Get full text
    Journal Article
  9. 9

    Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model by Yang, Vicky K., Loughran, Kerry A., Meola, Dawn M., Juhr, Christine M., Thane, Kristen E., Davis, Airiel M., Hoffman, Andrew M.

    Published in Journal of extracellular vesicles (01-12-2017)
    “…Myxomatous mitral valve disease (MMVD) is functionally and histologically identical to mitral valve prolapse (MVP) in humans. Currently, there are no medical…”
    Get full text
    Journal Article
  10. 10

    Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms by Oyama, Mark A., Elliott, Chad, Loughran, Kerry A., Kossar, Alexander P., Castillero, Estibaliz, Levy, Robert J., Ferrari, Giovanni

    Published in Cardiovascular pathology (01-05-2020)
    “…Myxomatous mitral valve degeneration (MMVD) is a leading cause of valve repair or replacement secondary to the production of mitral regurgitation, cardiac…”
    Get full text
    Journal Article
  11. 11

    Echocardiographic indices and severity of mitral regurgitation in dogs with preclinical degenerative mitral valve disease by Larouche‐Lebel, Éva, Loughran, Kerry A., Oyama, Mark A.

    Published in Journal of veterinary internal medicine (01-03-2019)
    “…Background Describing severity of mitral regurgitation (MR) in dogs with degenerative mitral valve disease (DMVD) is challenging. Hypothesis/Objectives Mitral…”
    Get full text
    Journal Article
  12. 12

    Observed and expected reliability of echocardiographic volumetric methods and critical change values for quantification of mitral regurgitant fraction in dogs by Loughran, Kerry A, Kraus, Marc S, Achilles, Erin J, Huh, Terry, Larouche-Lebel, Éva, Massey, Laura K, Gelzer, Anna R, Oyama, Mark A

    Published in Journal of veterinary internal medicine (27-09-2024)
    “…Reliability of echocardiographic calculations for stroke volume and mitral regurgitant fraction (RF ) are affected by observer variability and lack of a gold…”
    Get full text
    Journal Article
  13. 13

    Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure by Loughran, Kerry A., Larouche‐Lebel, Éva, Huh, Terry, Testani, Jeffrey M., Rao, Veena S., Oyama, Mark A.

    Published in Journal of veterinary internal medicine (01-11-2020)
    “…Background In human patients, cumulative urine volume (uVol) and urine sodium (uNa) can be predicted using spot urine samples and these quantitative measures…”
    Get full text
    Journal Article
  14. 14

    Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease by Li, Qinghong, Larouche-Lebel, Éva, Loughran, Kerry A., Huh, Terry P., Suchodolski, Jan S., Oyama, Mark A.

    Published in mSystems (20-04-2021)
    “…Gut dysbiosis and gut microbiota-derived metabolites, including bile acid (BA), short-chain fatty acid, and trimethylamine N-oxide (TMAO), are associated with…”
    Get full text
    Journal Article
  15. 15

    Reproducibility of geometric and flow-based echocardiographic measurements used for quantification of left ventricular total and forward stroke volume in healthy dogs by Loughran, K.A., Larouche-Lebel, É., Huh, T.P., Kraus, M.S., Oyama, M.A.

    Published in Journal of veterinary cardiology (01-08-2020)
    “…Cardiac structure and function in dogs are commonly assessed using echocardiography. A variety of linear, area, and flow-based measurements can be used to…”
    Get full text
    Journal Article